HYSINGLA ER
Drug
Purdue Pharma L.P.
Total Payments
$1.2M
Transactions
24,371
Doctors
9,348
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $4,440 | 1 | 1 |
| 2020 | $49,943 | 1 | 0 |
| 2019 | $45,415 | 5 | 3 |
| 2018 | $69,250 | 231 | 226 |
| 2017 | $999,301 | 24,133 | 9,299 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $581,757 | 549 | 49.8% |
| Food and Beverage | $318,578 | 23,602 | 27.3% |
| Consulting Fee | $175,925 | 16 | 15.1% |
| Unspecified | $49,943 | 1 | 4.3% |
| Travel and Lodging | $41,297 | 201 | 3.5% |
| Space rental or facility fees (teaching hospital only) | $850.00 | 2 | 0.1% |
Payments by Type
General
$1.1M
24,370 transactions
Research
$49,943
1 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Hydrocodone ER Feasibility Pediatrics | Purdue Pharma L.P. | $49,943 | 0 |
Top Doctors Receiving Payments for HYSINGLA ER — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Pain Medicine | Greenville, NC | $11,617 | 10 |
| , MD | Pain Medicine | Lutz, FL | $9,402 | 8 |
| , MD | Pediatric Critical Care Medicine | Durham, NC | $8,880 | 2 |
| , M.D | Pain Medicine | Huntington Beach, CA | $8,095 | 18 |
| , M.D | Anesthesiology | San Diego, CA | $7,897 | 10 |
| , MD | Pain Medicine | Meridian, MS | $7,860 | 11 |
| , MD | Anesthesiology | Arlington, TX | $5,391 | 7 |
| , MD | Pediatric Infectious Diseases | Durham, NC | $5,200 | 1 |
| , MD,PMR | Physical Medicine & Rehabilitation | White Plains, NY | $4,891 | 10 |
| , MD, PHD | Anesthesiology | Portland, OR | $4,184 | 10 |
| , D.O | Pain Medicine | St George, UT | $3,300 | 18 |
| , MD MPH | Internal Medicine | Durham, NC | $2,775 | 1 |
| , M.D | Pain Medicine | Morrow, GA | $2,397 | 9 |
| , M.D | Pain Medicine | Santa Monica, CA | $1,635 | 18 |
| , M.D | Pain Medicine | Delray Beach, FL | $1,596 | 10 |
| , D.O | Pain Medicine | Fort Worth, TX | $1,544 | 18 |
| , MD | Anesthesiology | Willow Grove, PA | $458.52 | 11 |
| , MD | Interventional Pain Medicine | Birmingham, AL | $391.11 | 8 |
| , MD | Pain Medicine | Charleston, SC | $342.16 | 4 |
| , DO | Anesthesiology | Reno, NV | $339.90 | 19 |
| , DO | Pain Medicine | Philadelphia, PA | $328.13 | 11 |
| , D.O | Anesthesiology | Austin, TX | $280.46 | 8 |
| , M.D | Pain Medicine | Pottstown, PA | $248.96 | 19 |
| , M.D | Physical Medicine & Rehabilitation | Arlington, VA | $248.07 | 15 |
| , MD | Pain Medicine | Baltimore, MD | $237.90 | 5 |
Ad
Manufacturing Companies
- Purdue Pharma L.P. $1.2M
Product Information
- Type Drug
- Total Payments $1.2M
- Total Doctors 9,348
- Transactions 24,371
About HYSINGLA ER
HYSINGLA ER is a drug associated with $1.2M in payments to 9,348 healthcare providers, recorded across 24,371 transactions in the CMS Open Payments database. The primary manufacturer is Purdue Pharma L.P..
Payment data is available from 2017 to 2021. In 2021, $4,440 was paid across 1 transactions to 1 doctors.
The most common payment nature for HYSINGLA ER is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($581,757, 49.8% of total).
HYSINGLA ER is associated with 1 research study, including "Hydrocodone ER Feasibility Pediatrics" ($49,943).